ABSTRACT
We have identified differences in arrhythmic risk and cardiac repolarization during nocturnal versus daytime hypoglycemia in young adults with type 1 diabetes. Asymptomatic hypoglycemia was common and our data support the concept of hypoglycemia as a proarrhytmogenic state.
Hypoglycemia is an inevitable consequence of the current management of type 1 diabetes (1).
Improved glycemic control is frequently accompanied by an increased risk of inducing iatrogenic hypoglycemia (2) . Observational studies indicate that rates of severe hypoglycemia have generally not fallen despite the introduction of insulin analogues and advanced methods of glucose monitoring (3, 4) . Hypoglycemia thus continues to be a major limiting factor in the management of type 1 diabetes.
It has been nearly three decades since Tatersall and Gill published their original report describing 22 nocturnal deaths of young people with type 1 diabetes (5) . The 'dead in bed syndrome' was characterized by young and otherwise healthy individuals with type 1 diabetes who had retired to bed in good health but were found dead in undisturbed beds on the following day. Subsequent autopsies could not establish a cause of death. Similar reports from other parts of the world have continued to appear in the literature (6) (7) (8) .
Nocturnal hypoglycemia has been consistently implicated, yet the precise mechanism remains unclear. A case report involving continuous interstitial glucose monitoring (CGM) has confirmed that hypoglycemia was present at the time of death (9) . Our group and others have reported QT interval prolongation during both experimental hypoglycemia in healthy individuals (10) and people with diabetes (11) as well as during clinical episodes (12) .
Abnormal cardiac repolarization during hypoglycemia appears to be mediated by both direct effect of sympathoadrenal stimulation and catecholamine and insulin-induced hypokalemia on cardiac ion channels (13) . Hypoglycemia is increasingly recognized as a potential proarrhythmic event (14) , but direct evidence linking electrocardiographic changes and the 'dead in bed' syndrome is missing (15) .
Given the fact that nocturnal hypoglycemia is very common and sudden deaths in type 1 diabetes are rare (6, 16) an interplay of several factors such as overt or undetected autonomic neuropathy, genetic contribution or abnormally intensive sympathoadrenal response are likely to contribute (14) . There is, however, considerable uncertainty in the way and extent in which these factors contribute to the development of the presumed malignant disturbances of cardiac rhythm (6, 17, 18) . Presumably only under certain circumstances a combination of these and perhaps other factors can lead to an unfavorable course of events resulting in a fatal outcome.
One of the defining characteristics of the 'dead in bed' syndrome is that it seems to occur only at night. A physiological diurnal variability in the autonomic tone with reduction in sympathetic tone and consequent relative increase in parasympathetic activity during sleep has been well documented (19) . Diminished epinephrine responses to experimental hypoglycemia during sleep in comparison to daytime hypoglycemia have been reported in people with type 1 diabetes and healthy individuals (20) . Additionally, we have recently reported differences in increased susceptibility to cardiac arrhythmias, heart rate variability (HRV) and cardiac repolarization during nocturnal and daytime hypoglycemia in people with type 2 diabetes with increased cardiovascular risk in a study design similar to the currently presented report (21) . We have hypothesized that similar diurnal differences in cardiac electrophysiological responses to hypoglycemia may exist in young people with type 1 diabetes and if so, could help to elucidate the pathophysiology of the 'dead in bed' syndrome.
The aim of this study was to examine the effect of clinical hypoglycemia in young people (≤ 50 years of age) with type 1 diabetes -as compared to matched euglycemia -on the frequency of cardiac arrhythmias, HRV and cardiac repolarization. We particularly sought to compare differences between nocturnal and daytime hypoglycemia given the above described diurnal differences in sympathetic adrenomedullary responses to hypoglycemia.
RESEARCH DESIGN AND METHODS
Thirty-seven individuals with type 1 diabetes below the age of 50 years and with duration of disease for at least 4 years were recruited from Sheffield Teaching Hospitals outpatient clinics. Participants taking beta-blocking and QT-interval prolonging agents were excluded. Calibrations were performed at least five times during the study period according to the manufacturer`s instructions. Mindful of the potential limitations of the CGM, we selected a system that with the lowest detection limit of 1.1 mmol/L (20 mg/dL) and with acceptable mean absolute differences between the interstitial glucose (IG) values and actual blood glucose levels (25) . Predictive alarms were switched off and participants were blinded to the real-time IG levels by disabling the display of IG values on the device. Participants were asked to keep a record of any symptomatic hypoglycemia in provided diaries. Any hypoglycemia episode, as defined in the next paragraph, without simultaneous self-report of symptoms in the diary was regarded as asymptomatic.
CGM Analysis
The IG was measured every minute by the CGM, and 10-min averages were reported The ratio between the LF power and total power (LF + HF power) was calculated (LFnorm).
HF power reflects parasympathetic activity. LFnorm was previously suggested to indicate the level of sympathetic modulation in HRV (29, 30) .
Repolarization Analysis
Repolarization analysis and detection of QT interval duration was performed using custombuilt, semiautomatic software based on a selective beat averaging approach (31) . Cubic spline interpolation and 40Hz low-pass filtering were applied to ECG leads. Average beats were calculated from stable normal beats within 5-min segments, centered on each IG value.
Analysis was performed on a composite wave, which was calculated by combining averaged beats derived from leads I, II, and V5 (31) . The onset of the Q wave was marked as the first positive deflection from the isoelectric line > 10 microvolts. The end of the T wave was determined using the tangent method, where the tangent to the steepest downslope of the T wave crosses the isoelectric line. All fiducial points were reviewed and adjusted if necessary by an observer blinded to glucose values. QT intervals were corrected for heart rate (QTc) using Bazett's formula (32) . Cardiac repolarization was characterized by calculating rateindependent parameters, including T-peak to T-end interval duration (TpTend) and symmetry of the T wave (Tsym) (33) . All parameters, including HRV indices were compared at hypoglycemia nadir vs matching euglycemia as described in the next paragraph.
Statistical Analysis
This was an observational study, and thus no power calculations were performed. The numbers chosen were based upon an assessment of the number of patients it was possible to examine given the constraints on recruitment and projected hypoglycemia rates. Data were inspected for normality. Data that followed an approximate normal distribution were summarized using mean ± SD, while skewed data were summarized using the median (IQR).
Median duration and median nadir values of nocturnal and daytime hypoglycemic episodes were compared using the Mann-Whitney U test. The generalized estimated equations approach was used to investigate the effect of glycemic status on arrhythmia counts while taking into account correlated measurements from individuals who experienced more than one episode of hypoglycemia or hyperglycemia. Data were fitted with a negative binomial model with the assumption that rates for individuals came from a distribution with a mixed but non-zero variance. This allows modelling of variables that are over-dispersed (i.e. where the sample variance exceeds the sample mean) relative to a Poisson model which is usually used in analyzing count data. A first-order autoregressive correlation structure was applied to adjust for within-individual correlation. Exponentiated regression coefficients represent incident rate ratios (IRRs). The IRRs of arrhythmias during hypoglycemia compared with euglycemia were calculated adjusting for the longer period participants were at euglycemic levels compared to the period spent in hypoglycemia . HRV, corrected QT intervals (QTc) and repolarization parameters were compared at the hypoglycemia nadir against an equivalent euglycemic time point on a different day. Where there was more than one matching hypoglycemic-euglycemic episode in an individual participant over the course of the recording period, the mean values from all daytime and nocturnal episodes from that individual were reported. Data were compared using a paired t-test or the Mann-Whitney U test. Statistical analysis was performed with SPSS (version 22; IBM, Chicago, Illinois, USA).
A p value ≤ 0.05 was deemed statistically significant. 
RESULTS

Nocturnal and Daytime Hypoglycemia Characteristics
Altogether 44 nocturnal and 69 daytime hypoglycemic episodes were analyzed. There were diurnal differences in the duration of hypoglycemic episodes ( 
Arrhythmias during Nocturnal and Daytime Hypoglycemia
We compared total and relative frequencies of distinct types of arrhythmias during hypoglycemia versus euglycemia during night and day. Total frequencies of arrhythmias were low (Supplementary Table 1 ). However, comparison of relative frequencies showed several differences between hypoglycemia and euglycemia and between nocturnal and 
CONCLUSIONS
To the best of our knowledge this is the largest observational study to date examining the effect of spontaneous hypoglycemia in young people with type 1 diabetes on frequency of cardiac arrhythmias, heart rate variability (HRV) and cardiac repolarization and the first study that directly compares diurnal differences in these characteristics. We confirmed that hypoglycemia and particularly asymptomatic hypoglycemia continues to occur frequently in young people with type 1 diabetes. We also observed several differences in cardiac electrophysiological responses to hypoglycemia between day and night. We saw increased risk of bradycardia during nocturnal hypoglycemia whereas during daytime hypoglycemia, bradycardia was significantly lower and frequency of atrial ectopics significantly higher in comparison to euglycemia. Cardio-acceleration was detected during daytime hypoglycemia but not during nocturnal hypoglycemia. Lastly, we confirmed a pro-arrhythmogenic effect of hypoglycemia by showing significant prolongation of QTc interval and TpTend interval together with a change towards abnormal, symmetric shape of the T wave both during night and day.
One of the main objectives of this study was to explore the different effects of nocturnal and daytime hypoglycemia on frequency of cardiac arrhythmias, HRV and cardiac repolarization.
Factors which might affect these responses include diurnal variability in autonomic tone (19) , different sympathoadrenal response to hypoglycemia when awake or asleep (20) and the effect of body position (34) . Previous studies in this field have either compared measurements of cardiac repolarization during hypoglycemia to those at euglycemia immediately before hypoglycemia (26) or averaged HRV and repolarization across the total duration of episodes (35) . We chose to compare measurements at glucose nadir. In this way we hoped to avoid a bias due to a variable length of episodes (the range of the duration ranged from 20 to 460 minutes) as well as averaging out the changes during phasic responses in episodes of long duration. We also controlled robustly for diurnal increases in arrhythmic risk by comparing changes during a matched period of euglycemia at the same time on a different day.
However pre-defining a hypoglycaemic episode precisely imposes its own limitation. By only counting hypoglycemic episodes that lasted at least 20 min, we probably underestimated the amount of hypoglycaemia. Nevertheless since we defined euglycemia as a glucose concentration between 5-10 mmol/l, we are confident that periods defined as euglycemia (to control for circadian influences on arrhythmias) were calculated accurately. A further limitation was the 70% return rate of questionnaires used to identify symptomatic responses.
While this probably represents a reasonably good return in an observational clinical study our estimates of symptomatic and asymptomatic hypoglycaemia must be regarded with some uncertainty.
Absolute numbers of arrhythmias in the studied population were low meaning that we were unable to measure the changes in sub-groups, such as those with CAN. The majority of cardiac arrhythmias occurred during euglycemia, since periods of euglycemia were more frequent and long-lasting compared to hypoglycemia. Relative risks for distinct types of arrhythmias during hypoglycemia versus euglycemia are reflected by presented incident rate ratios (IRRs). The applied statistical model was used to adjust for uneven distribution of hypoglycemic episodes and cardiac arrhythmias among studied individuals as well as to adjust for individuals with no episodes and those who experienced multiple episodes of hypoglycemia. However, arrhythmia incident rate ratios are weighted by data from individuals who are more prone to arrhythmias and the findings need to be confirmed by studies in different populations.
The QT interval duration varies according to heart rate and different formulas are used to correct for heart rate, of which Bazett`s correction is the most commonly used. The Bazett`s formula corrects intervals to a rate of 60 bpm and tends to result in overcorrection at high heart rates and under-correction at lower heart rates. Nevertheless, it is generally considered a reasonably accurate correction in the setting of hypoglycemia (36) . In our study we In the light of the potential limitations of heart rate correction, we also included measurements of rate-independent indicators of cardiac repolarization: T-peak to T-end interval duration (TpTend) and symmetry of the T wave (Tsym) (33) . TpTend is a measure of dispersion of repolarization in the left ventricle; its prolongation is considered to represent a period of potential vulnerability to re-entrant ventricular dysrhythmias and is associated with increased risk of sudden cardiac death (38) . We detected significant prolongation of TpTend in both nocturnal and daytime hypoglycemia. Symmetrical T waves can be found in various pathological states and computational models show that T waves become more symmetrical with an increase in the dispersion of repolarization (39) . In our study T waves did not become totally symmetric (Tsym = 1) but we found a consistent change towards more symmetrical shape during hypoglycemia both during day and night.
Cardio-acceleration and a trend towards vagal withdrawal were observed during daytime hypoglycemia together with greater increase in QTc. In contrast, during nocturnal hypoglycemia no changes in HRV were detected and QTc increases were smaller. We reported similar findings in an ambulatory study in type 2 diabetes (21) . One potential mechanism is a predominance of sympathoadrenal response during the day compared to the night where sympathoadrenal activation may be suppressed by prone posture and during sleep (21) .
In contrast to differences in the magnitude of QTc prolongation, the observed changes in rateindependent characteristics of cardiac repolarization (TpTend, Tsym) during daytime and nighttime hypoglycemia are rather similar. This suggests that during hypoglycemia, cardiac repolarization is influenced by factors additional to cardiac autonomic responses, perhaps hypokalemia or hypoglycemia per se. In this observational study no direct measurements of catecholamine or potassium levels were possible.
Increased frequency of bradycardias during nocturnal hypoglycemia in young people with type 1 diabetes might be clinically relevant given the fact that bradycardia may lead to early afterdepolarizations (EADs) via increased intracellular Ca 2+ concentration in cardiomyocytes (40) . EADs represent one of the most important arrhythmogenic mechanisms promoting arrhythmias in acquired and congenital long QT syndromes including torsade des pointes, polymorphic ventricular tachycardia and ventricular fibrillation (40) . Additionally, diabetes and hypoglycemia per se are linked with increased incidence of EADs independent of heart rate (14) . Nocturnal hypoglycemia with concomitant bradycardia in people with diabetes thus represents an event with increased proarrhythmogenic potential. We have previously reported an increased risk of bradycardias during spontaneous nocturnal hypoglycemia in people with type 2 diabetes at increased cardiovascular risk (21) . The findings in the present study suggest that this hypoglycemia-induced mechanism is independent of the type of diabetes, age or cardiovascular risk profile. Importantly, our observations that certain types of arrhythmia (for example, bradycardia) were confined to just a few subjects suggest that susceptibility to arrhythmias during hypoglycaemia is highly individual. The increasing use of CGM as a clinical rather than a research tool might permit screening of individuals with type 1 diabetes to identify those at high arrhythmic risk.
In summary, we have shown a contrast in the frequencies of arrhythmias and cardiac electrophysiological responses during nocturnal compared to daytime hypoglycemia. We confirm a high frequency of hypoglycemia, particularly of nocturnal asymptomatic episodes among young people with type 1 diabetes and our data add to the body of evidence suggesting that hypoglycemia is pro-arrhythmogenic. Tables   Table 1 -Baseline participant characteristics Number of participants , n 37 pressure, DBP -diastolic blood pressure. CAN -cardiac autonomic neuropathy. DSPNchronic sensorimotor distal symmetrical polyneuropathy. *Microalbuminuria was defined as albumin/creatinine ratio ≥ 2.5 mg/mmol (men) and ≥ 3.5 mg/mmol (women) on 2 separate measurements at least 6 months apart. †Macroalbuminuria was defined as albumin/creatinine ratio > 30 mg/mmol. eGFR -estimated glomerular filtration rate (CKD-EPI formula).
CKD1-3 -chronic kidney disease stages 1-3. also Table 3 ) and therefore no IRR could be calculated for this type of arrhythmia. Psignificance of difference in arrhythmia rates during hypoglycemia vs. euglycemia.
